`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX CORP.,
`Petitioner
`
`v.
`
`ALCON RESEARCH, LTD.,
`Patent Owner.
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299 B2
`
`
`
`
`NOTICE OF JOINT STIPULATION TO EXTEND DUE DATES 2–3
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299
`
`
`
`
`
`
`.
`
`
`Pursuant to the January 2, 2014 Scheduling Order (Paper 10), and further to
`
`the Notice of Joint Stipulation to Extend Due Dates 1-3 of February 3, 2014,
`
`petitioner Apotex Corp, (“Apotex”) hereby provides notice that Alcon Research,
`
`Ltd. (“Alcon”) and Apotex have agreed to extend Due Dates 2–3, as follows:
`
`DUE DATE 1 ..................................................................................... March 24, 2014
`March 27, 2014
`
`Patent owner’s response to the petition
`
`Patent owner’s motion to amend the patent
`
`
`
`
`
`
`
`DUE DATE 2 ........................................................................................ June 16, 2014
`June 19, 2014
`July 31, 2014
`
`Petitioner’s reply to patent owner response to petition
`
`Petitioner’s opposition to motion to amend
`
`
`
`
`
`
`
`DUE DATE 3 ......................................................................................... July 14, 2014
`July 17, 2014
`August 1, 2014
`
`
`
`
`
`
`
`
`
`Patent owner’s reply to petitioner opposition to motion to amend
`
`In accordance with the Scheduling Order, Due Dates 4–7 remain as follows:
`
`DUE DATE 4 ...................................................................................... August 4, 2014
`
`
`
`2
`
`
`
`
`Case IPR2013-00428
`
`U.S. Patent No. 8,268,299
`
`Petitioner’s motion for observation regarding
`cross-examination of reply witness
`
`Motion to exclude evidence
`
`Request for oral argument
`
`
`
`
`
`
`
`.
`
`
`DUE DATE 5 .................................................................................... August 18, 2014
`
`Patent owner’s response to observation
`
`Opposition to motion to exclude
`
`
`
`
`
`
`
`DUE DATE 6 .................................................................................... August 25, 2014
`
`Reply to opposition to motion to exclude
`
`
`
`
`
`DUE DATE 7 .............................................................................. September 17, 2014
`
`
`
`Oral argument (if requested)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299
`
`
`
`
`
`.
`
`
`Additionally, in light of the adjustments to the schedule, Petitioner and
`
`Patent Owner have jointly agreed to postpone the depositions of Patent Owner’s
`
`witnesses Noticed to the Board in Papers filed May 1, 2014.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Eldora L. Ellison/
`Eldora L. Ellison, Ph.D. (Reg. No. 39,967)
`Lead Attorney for Petitioner Apotex Corp.
`
`
`
`
`
`Date: May 13, 2014
`
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`
`
`The undersigned hereby certifies that a copy of the foregoing “Notice of Joint
`
`Stipulation to Extend Due Dates 2-3” was served in its entirety on May 13, 2014,
`
`via email upon the following counsel of record for the Patent Owner:
`
`
`
`
`
`
`
`
`Stanley E. Fisher
`David M. Krinsky
`Adam L. Perlman
`Barry L. Copeland
`
`
`
`
`
`sfisher@wc.com
`dkrinsky@wc.com
`aperlman@wc.com
`barry.copeland@alcon.com
`patent.docketing@alcon.com
`
`
`
`
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /Eldora L. Ellison/
` Eldora L. Ellison, Ph.D.
`Date: May 13, 2014
` Lead Attorney for Petitioner Apotex Corp.
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 39,967
`Washington, D.C.20005-3934
`(202) 371-2600
`1850814
`
`